About Ronald Lennox
Form D filings for Octagon Therapeutics in 2024 list Ronald Lennox as director.
Ronald Lennox first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Ronald Lennox in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ronald Lennox works with at each company, as listed on that company's latest Form D.
Octagon Therapeutics, Inc. · Form D, Feb 12, 2024
Isaac Stoner
President and director
TS
Thorne Sparkman
Director